Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Charles Marwick This article originally appeared in BMJ USA
Washington The rule was issued by the Department of Health and Human Services
(HHS) at the end of December. It lays out standards for protecting
personal health records of all types The origins of the rule go back to 1996, when Congress, recognizing the
need for national standards for patient records privacy, passed the
Health Insurance Portability and Accountability Act (HIPAA). This law
gave Congress until August 1999 to pass comprehensive health privacy legislation.
But after three years of debate Congress could not reach a consensus
and, under the Act, the job of drafting a rule passed to HHS. HHS
issued a proposal in November of that year and received over 52 000
comments Publication of the rule was among the last acts of the Clinton
administration. On February 23, new HHS Secretary Tommy Thompson announced that the department will re-examine the rule and re-open it
for a 30-day public comment period. One consideration that will
undoubtedly come into play is that the effort to protect the privacy of
medical records is very popular with the public. Any steps that delay
or appear to water down the rule are likely to be politically unacceptable.
One group, however, wants action. At the end of January, the American
Hospital Association (AHA) requested Secretary Thompson to reopen the
rule for further comment. Doing so, said Rick Pollack, the
Association's executive director, will give hospitals an opportunity to fully gauge the impact of the privacy rules, reform them where necessary, and find additional sources for funds needed to implement them. Mr Pollack said that the rule will be "exceedingly costly" to
implement. An AHA study puts the cost at more than $22 billion over a
five-year period. HHS estimates the cost as more than $17 billion over
10 years.
Dr Gail Wilensky, health policy adviser to President Bush, believes
that the new Administration will need to consider the impact of the new
privacy rule. But revising it is something else, she pointed out in an
interview. "It's not easy to revise a rule after it has been
published," she said. If the Administration decides to do so, "it
will be necessary to go through the whole rule-making process." She
noted the continuing widespread concerns raised by providers about the
implications of the rule.
"We do like certain things about the rule," says Dr Donald J. Palmisano, a member of the AMA's Board of Trustees, in an interview. "We agree that patient privacy should be protected. The AMA has been
in the forefront of this effort. Also, we like the fact that the rule
sets a floor, not a ceiling. States, in other words, can make stricter laws."
Meanwhile, it seems unlikely that the average practicing physician has
given the rule and its implementation much thought. "I think it is
very doubtful that physicians are thinking about them now," said a
spokesperson for the American Academy of Family Physicians. The Academy
is developing educational materials for its members to help them comply
with the new privacy regulations when they go into effect.
The AMA is advising its members to adopt a wait-and-see attitude, for
several reasons. Although the privacy rule goes into effect on February
26th, there is a two-year period before it is enforced. Also, the
privacy rule is only one of several new federal regulations concerning
patient data; others are still to be published. One of these other
regulations, for example, will set standards for the security of
electronic transmission of medical data.
The other new regulations are likely to have an impact on the privacy
rule, said Dr Palmisano. "So, we are encouraging physicians not to
rush out and buy a lot of new software or whatever in order to comply,
when other regulations may supplant it." HHS estimates the cost to
the individual physician of implementing the rule at around $4000.
One aspect of the new rule that irks doctors is that it assumes that
keeping health information confidential is a physician problem.
"Physicians are not the problem with patient privacy. It's in our
ethical precepts to keep confidential information about their health
that people tell us," said Dr Palmisano.
He characterizes the privacy rule as treatment for a disease that does
not exist in the doctor's office. "The entities that are most likely
to wrongfully disclose and to misuse confidential information are those
not covered by the rule Meanwhile the rule's drafters are not dismayed by the controversy.
They are reported to have taken the position that since no one seemed
happy with the rule, they must have done something right.
As the final rule aimed at protecting the
privacy of patients' medical records goes into effect, it is giving
rise to just as much controversy as it generated when it was being drafted. The criticisms come, not just from health insurers, hospitals, and the health care industry (who say it will impose unacceptable costs), but also from significant segments of the medical profession, such as the American Medical Association (AMA) and the American Psychiatric Association (APA). At the same time, among the professional medical groups at least, there is agreement that it is better than
nothing. The AMA has long supported patient records protection, but
points out that the final rule does not fully achieve that goal.
electronic, paper and even oral
communications. "This is what American patients and their providers
want and need," said Dr Donna Shalala, the previous HHS Secretary,
speaking at a press conference. She hailed the rule as a landmark in
achieving privacy of medical records.
itself a measure of the widespread interest in the topic.
the insurers, the employers, the contractors,
the marketers, the life insurance people. Most of these abuses will not
be resolved by this regulation," said Dr Palmisano. "What is really
needed is a comprehensive regulation that would apply to the release of
all patient information."
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.